Copyright
©2012 Baishideng Publishing Group Co.
World J Cardiol. Jun 26, 2012; 4(6): 195-200
Published online Jun 26, 2012. doi: 10.4330/wjc.v4.i6.195
Published online Jun 26, 2012. doi: 10.4330/wjc.v4.i6.195
Transthoracic echocardiogram | Left ventricle systolic dysfunction has long been known to be associated with thromboembolism in atrial fibrillation and is currently used in the CHA2DS2-VASc score[4] |
Left atrial diameter was shown to be associated with thromboembolism in old studies. Nowadays, diameter is not considered an appropriate way of assessing left atrial size[21] | |
Left atrial area and volume have been shown to be associated with the presence of left atrial appendage thrombus and other markers of left atrial stasis[22]. Studies concerning hard clinical endpoints are still lacking[23] | |
Left atrial deformation assessment (strain and strain rate) holds promise in this field, since it translates changes in atrial kinetics and function | |
Transesophageal echocardiogram | Left atrial appendage thrombus, spontaneous echocardiographic contrast and low flow velocities in the left atrial appendage have been associated with a high risk of thromboembolic events and an adverse prognosis[22] |
The invasive nature of this technique makes it inadequate for wide usage in AF patients |
- Citation: Providência R, Paiva L, Barra S. Risk stratification of patients with atrial fibrillation: Biomarkers and other future perspectives. World J Cardiol 2012; 4(6): 195-200
- URL: https://www.wjgnet.com/1949-8462/full/v4/i6/195.htm
- DOI: https://dx.doi.org/10.4330/wjc.v4.i6.195